Pfizer (NYSE:PFE) is currently dealing with shareholder proposals concerning governance issues such as religious ...

The latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.

The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...

Since that time, though, demand for these products has declined, and that's resulted in lower revenue and a drop in the Pfizer share price. Right now, as an investor, you may be wondering if you ...

(NYSE:PFE) shareholders, since the share price is down 43% in the last three years, falling well short of the market return of around 38%. While the last three years has been tough for Pfizer ...

Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...

Involves transaction of at least 0.5% of the listed shares of a company. Pfizer Ltd share price was down by -1.36% from the previous closing price of ₹4,148.35. Who are peers of Pfizer Ltd?

BioNTech's Q4 revenue beat estimates despite lower COVID-19 vaccine sales. The company advances oncology programs, with key ...